Nichols (NICL)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 1,085.00 |
|---|---|
| 52-week range | 880.00 – 1,200.00 |
| Return, 1 month / 3 months | −2.7% / +11.5% |
| Return, 1 year / 3 years | +5.4% / +37.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 27.2% |
| Worst drawdown (1 year) | -15.8% |
| Average daily value traded | 59.78M GBX |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nichols is a British soft drinks company based in the north of England. It makes and sells cordials, squashes and ready-to-drink soft drinks, most notably under the Vimto brand, along with other owned and licensed drink brands. Its customers include supermarkets, convenience stores and other retailers, and it also supplies drinks and dispense equipment to pubs, restaurants and other outlets through its beverage systems operations. The company sells in the UK and in overseas markets.
The shares are listed on the London Exchange in UK under the code NICL, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nichols (NICL) trades on the London Exchange in UK. It last closed at GBX 1,085.00 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 251 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.4% and over the last three months it rose 11.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.6% | ||
| From 52-week high | -7.3% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.5% | ||
| 6-month return | 17.2% | ||
| 12-month return, skipping the last month | 8.3% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.8% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 59.78M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −2.7% |
| 3 months | +11.5% |
| 6 months | +17.2% |
| 1 year | +5.4% |
| 3 years | +37.0% |
| 5 years | +9.0% |
Signals
| 50-day / 200-day average | 1,114.10 / 989.68 |
|---|---|
| Golden / death cross (60 days) | Golden, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 51.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.2020 |
| 19 Mar 2026 | GBP 0.1870 |
| 7 Aug 2025 | GBP 0.1500 |
| 20 Mar 2025 | GBP 0.1710 |
| 1 Aug 2024 | GBP 0.6970 |
| 21 Mar 2024 | GBP 0.1560 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.